摘要:
A compound represented by the following general formula (I) (wherein R1 represents hydrogen, hydroxy, or alkoxy; R2 represents hydroxy or optionally substituted alkoxy; R3 represents hydrogen or optionally substituted alkyl; Y represents -CH=CH- or -CH2-; n is 0 or 1; and Ar represents optionally substituted aryl or optionally substituted heteroaryl) or a salt of the compound. They are useful as an abscisic acid biosynthesis inhibitor or plant growth regulator.
摘要:
The present invention provides compounds, pharmaceutical compositions and methods for treating, immuno-allergical diseases, autoimmune diseases, and organ or tissue rejection following transplantation.
摘要:
2-Aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory pathologies (particularly septic shock) and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained.
摘要:
2-Aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory pathologies (particularly septic shock) and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained.
摘要:
Phellodendrine analogs represented by general formula (I), wherein A represents the group (a); B represents hydrogen, lower alkyl or lower acyl, or alternatively A and B together with the adjacent nitrogen atom form a substituted 1,2,3,4-tetrahydroisoquinoline ring represented by general formula (II), R11, R12, R21, R22, R31 and R32 represent each hydrogen, hydroxyl or lower alkoxy; n1 represents a number of 0 to 2; n2 represents a number of 1 and 2; and m1 represents a number of 0 to 1, provided tsat when A represents the group (b), and n2 is 2, B is lower acyl, and that when A and B together form a substituted 1,2,3,4-tetrahydroisoquinoline ring, n1 is 1 and m1 is not 0. These analogs (I) and related compounds have an excellent activity of suppressing allergy type IV and hence are utilizable as a medicine efficacious against diseases wherein allergy type IV participates, such as chronic hepatitis, intractable asthma, nephrotic syndrome or rheumatism.
摘要:
The invention relates to a process for the production of an acid addition salt of a dobutamine compound of the general formula
wherein
R is a hydrogen atom or a methyl group, and n is 1 or 2, by reacting a mineral acid - addition salt of a dopamine compound of the general formula
with a ketone of the general formula
under the influence of a catalytic amount of a base, and in the presence of hydrogen and a hydrogenation catalyst, after which the pH of the reaction mixture is adjusted to approx. 6 at most and the product is isolated.
摘要:
Arylalkylamines (as the hydrochloride salt), e.g. tyramine hydrochloride, are prepared by hydrogenating substituted or unsubstituted aryl-α-oximinoalkyl ketones, e.g. p-hydroxyisonitroacetophenone, in either in an aqueous reaction medium comprising hydrochloric acid, essentially without the presence of a lower alkyl alcohol in said reaction medium, or in an aqueous reaction medium comprising water, hydrochloric acid, and a lower alkyl alcohol, wherein the alcohol comprises less than about 90% by volume of the reaction medium. A substituent on the aryl portion of the aryl-α-oximinoalkyl ketone must be on a position which activates the aromatic ring.
摘要:
There is provided the use of a compound of formula I in the preparation of a medicament for use in the prevention or treatment of neurological disorders, wherein, Ar₁ and Ar₂, which may be the same or different, independently represent phenyl substituted by one or more of amino, nitro chlorine, bromine, hydroxy, C1 to 6 alkoxy, C1 to 6 alkyl or cyano; in addition one of Ar₁ or Ar₂ may also represent phenyl; R₁ represents hydrogen or C1 to 6 alkyl; R₂ represents hydrogen or COCH₂NH₂; R₃ represents hydrogen or C1 to 6 alkyl; provided that when R₂ represents hydrogen, then one or both of Ar₁ and Ar₂ may also represent phenyl, fluorophenyl or 2-, 3- or 4- pyridinyl and R₁ may also represent C1 to 6 alkoxycarbonyl or trifluoromethyl; or a pharmaceutically acceptable salt thereof. Some of the compounds of formula I are novel, and there are provided processes for making these, together with processes for making pharmaceutical compositions containing the novel compounds.
摘要:
Compounds of formula I, in which R₁ represents OH, NR₁₁R₂₁, CH₂R₁₂, or fluorine, W represents a single bond, 1,2-,1,3- or 1,4-phenylene; a -CH=CH-group or a 1,4-cyclohexanediyl group; X represents NH, 0, S, SO₂, CO, CH₂, CONH or -COO; Y represents inter alia (CH₂) q , CO, CS or SO₂ Z represents a single bond, NR₁₉, CH₂, 0, CO, S or SO₂, and the other terms are as defined in the specification, and pharmaceutically acceptable derivatives thereof, possess useful pharmacological activity.